REPLIGEN CORPORATION

NASDAQ: RGEN (Repligen Corporation)

Kemas kini terakhir: 6 hari lalu, 1:58AM

113.52

1.42 (1.27%)

Penutupan Terdahulu 112.10
Buka 113.53
Jumlah Dagangan 809,337
Purata Dagangan (3B) 830,314
Modal Pasaran 6,377,905,152
Harga / Pendapatan (P/E Ke hadapan) 71.43
Harga / Jualan (P/S) 9.90
Harga / Buku (P/B) 4.11
Julat 52 Minggu
102.97 (-9%) — 182.52 (60%)
Tarikh Pendapatan 29 Jul 2025
Margin Keuntungan -3.53%
Margin Operasi (TTM) 5.59%
EPS Cair (TTM) -0.420
Pertumbuhan Hasil Suku Tahunan (YOY) 10.40%
Pertumbuhan Pendapatan Suku Tahunan (YOY) 76.90%
Jumlah Hutang/Ekuiti (D/E MRQ) 34.44%
Nisbah Semasa (MRQ) 6.79
Aliran Tunai Operasi (OCF TTM) 145.69 M
Aliran Tunai Bebas Leveraj (LFCF TTM) 183.66 M
Pulangan Atas Aset (ROA TTM) 0.92%
Pulangan Atas Ekuiti (ROE TTM) -1.16%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Medical Instruments & Supplies (US) Menurun Menurun
Medical Instruments & Supplies (Global) Menurun Menurun
Stok Repligen Corporation Menurun Menurun

AISkor Stockmoo

1.4
Konsensus Penganalisis 4.0
Aktiviti Orang Dalam NA
Volatiliti Harga 1.5
Purata Bergerak Teknikal 2.5
Osilator Teknikal -2.5
Purata 1.38

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
RGEN 6 B - - 4.11
ICUI 3 B - - 1.61
NNNN 2 B - 851.00 109.27
BLFS 1 B - - 3.09
ATRI 807 M 1.91% 43.11 3.39
KRMD 170 M - - 9.80

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Sektor Healthcare
Industri Medical Instruments & Supplies
Gaya Pelaburan Small Core
% Dimiliki oleh Orang Dalam 6.41%
% Dimiliki oleh Institusi 105.07%
370.15370.15314.20314.20258.25258.25202.30202.30146.35146.35Harga Sasaran MedianQ3 '20Q3 '20Q4 '20Q4 '20Q1 '21Q1 '21Q2 '21Q2 '21Q3 '21Q3 '21Q4 '21Q4 '21Q1 '22Q1 '22Q2 '22Q2 '22Q3 '22Q3 '22Q4 '22Q4 '22Q1 '23Q1 '23Q2 '23Q2 '23Q3 '23Q3 '23Q4 '23Q4 '23Q1 '24Q1 '24Q2 '24Q2 '24Q3 '24Q3 '24Q4 '24Q4 '24Q1 '25Q1 '25Q2 '25Q2 '25Q3 '25Q3 '25
Julat 52 Minggu
102.97 (-9%) — 182.52 (60%)
Julat Harga Sasaran
130.00 (14%) — 204.00 (79%)
Tinggi 204.00 (RBC Capital, 79.70%) Beli
Median 160.00 (40.94%)
Rendah 130.00 (Evercore ISI Group, 14.52%) Pegang
Purata 163.80 (44.29%)
Jumlah 4 Beli, 1 Pegang
Harga Purata @ Panggilan 122.35
Syarikat Tarikh Harga Sasaran Panggilan Harga @ Panggilan
RBC Capital 30 Jul 2025 204.00 (79.70%) Beli 122.85
Wells Fargo 30 Jul 2025 175.00 (54.16%) Beli 122.85
Stephens & Co. 22 Jul 2025 160.00 (40.94%) Beli 114.12
Evercore ISI Group 08 Jul 2025 130.00 (14.52%) Pegang 128.56
Barclays 24 Jun 2025 150.00 (32.14%) Beli 123.35

Tiada data dalam julat masa ini.

134.39134.39125.80125.80117.21117.21108.62108.62100.04100.04Jul 29Jul 29Jul 30Jul 30Jul 31Jul 31Aug 1Aug 1Aug 4Aug 4Aug 5Aug 5Aug 6Aug 6Aug 7Aug 7

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

10010075755050252500RSI (14H)
0.0000.000-1.000-1.000-2.000-2.000-3.000-3.000-4.000-4.000MACD (12, 26, 9)

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2025 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda